Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AmerisourceBergen 174.69 0.17 0.10% 18.93%
Elevance Health 480.43 9.41 2.00% -3.42%
Cardinal Health 84.76 0.17 0.20% 57.72%
Cigna 262.81 5.74 2.23% 1.74%
Centene 67.34 0.88 1.32% -19.10%
Computer Programs Systems 24.58 -0.69 -2.73% -24.58%
Charles River Laboratories 199.11 -1.57 -0.78% -18.74%
Catalent 37.80 0.08 0.21% -66.02%
CVS Health 70.79 0.76 1.09% -26.04%
Quest Diagnostics 134.22 -1.34 -0.99% -1.19%
General Electric 104.24 -1.56 -1.47% 35.38%
Humana 524.13 3.35 0.64% 18.02%
IQVIA Holdings 204.01 2.64 1.31% -7.60%
Laboratory Of America 217.78 0.80 0.37% -10.00%
McKesson 395.47 5.31 1.36% 24.49%
Veradigm Inc 11.65 -0.65 -5.28% -33.08%
Maximus 81.22 -2.04 -2.45% 27.28%
Molina Healthcare 293.14 5.97 2.08% 2.26%
Omnicell 73.37 -0.61 -0.82% -35.65%
Owens Minor 21.10 -0.23 -1.08% -37.11%
UnitedHealth 498.37 -1.39 -0.28% 1.67%
Veeva Systems 193.45 -1.55 -0.79% 2.38%
Walgreens Boots Alliance 31.25 0.06 0.19% -27.98%
Xerox 14.24 -0.54 -3.65% -25.41%

Indexes Price Day Year
USND 13229 -11.34 -0.09% 9.68%

Veradigm Inc

Veradigm Inc traded at $11.65 this Monday June 5th, decreasing $0.65 or 5.28 percent since the previous trading session. Looking back, over the last four weeks, Veradigm Inc lost 3.24 percent. Over the last 12 months, its price fell by 33.08 percent. Looking ahead, we forecast Veradigm Inc to be priced at 11.94 by the end of this quarter and at 10.93 in one year, according to Trading Economics global macro models projections and analysts expectations.